STAT
STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program
The White House has used the program to reward companies that help its political goals.
health · source
STAT News on WeSearch
Recent health headlines from STAT News.
STAT
What happens at a longevity festival?
The longevity festival known as Vitalist Bay challenges the stereotype of the movement being solely for the wealthy.…
STAT
Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story
An oncologist shares three lessons from the world’s first randomized trial on a multi-cancer early detection.
STAT
Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise
“One of the cancer community’s worst fears is coming to pass,” writes Gwen Nichols of Blood Cancer United.
STAT
Male puberty is understudied — but when it starts may predict long-term health risks
Due to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys…
STAT
STAT+: After hospitals, patients get a turn to bring AI into the doctor’s office
Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them as…
STAT
STAT+: What the pope’s encyclical on AI means for Catholic hospitals, and all of health care
The pope's encyclical on artificial intelligence addresses its implications for Catholic hospitals and the broader…
STAT News
STAT+: Legend Biotech emerged as a rare market winner
New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout
STAT
Opinion: The Amish way of health care
“Public health is going to have to talk about the Amish more and more”: Listen to STAT’s "First Opinion Podcast" on…
STAT
Opinion: The medical-billing AI arms race between providers and insurance
“The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.
STAT
Opinion: How the military may be fueling eating disorders in men
“Much of the rhetoric, imagery, and policy messaging from the Trump administration centers on extreme masculine…
STAT
STAT+: Trump’s Medicaid work requirements have an unwelcome surprise for some states and patients
Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.
STAT
STAT+: NIH cuts weakened network primed to respond to outbreaks like Ebola
While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers…
STAT
Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’
A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.
STAT
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop…
STAT
How one state’s medical meal program lowered health care costs
A new medical meal program in one state has shown promise in reducing healthcare costs. The initiative focuses on…
STAT
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data…
STAT
As FDA misses deadline on electric shock ban, disability advocates speak out
The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual…
STAT
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast”…
STAT
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall…
STAT
CDC says containing the spread of Ebola is top priority
The CDC has emphasized that containing the Ebola outbreak in the Democratic Republic of Congo and Uganda is its top…
STAT
STAT+: A turning point for pancreatic cancer patients
Recent advancements in pancreatic cancer treatment have been highlighted, particularly the promising results of…
STAT
STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drug
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55…
STAT
STAT+: A standing ovation for RevMed, and caution for Akeso
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
STAT
STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse…
STAT
STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug
Much-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in…
STAT News
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
STAT News
STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and…
STAT
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
STAT News
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.
STAT News
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
At the ASCO annual meeting, Bristol-Myers Squibb presented positive data regarding its treatment for multiple myeloma.…
STAT News
STAT+: Allogene CEO David Chang stepping down
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news…
STAT News
Which vaccines will curb the Ebola outbreak? WHO debates
The WHO is currently debating which vaccines and therapeutics should be tested to combat the ongoing Bundibugyo Ebola…
STAT News
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical…
STAT
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.
STAT
STAT+: The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of…
STAT
STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
Biotech veteran Jeremy Levin discusses the future of the biotech industry and the challenges it faces. He highlights…
STAT
An ASCO preview: What to watch for at cancer research’s big meeting
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.
STAT News
STAT+: Heart patch engineered from stem cells revved up weakened hearts
A stem cell-based heart patch improved pumping in a small trial for advanced heart failure. "Very good first step,"…
STAT News
Kailera’s own ‘triple-G’ drug also looks very powerful
The business of living forever, Chan Zuckerberg Biohub's AI protein model, and other biotech news from The Readout
STAT
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel…
STAT
Trump says latest medical exam went ‘PERFECTLY’
The conference where death is (theoretically) optional, new trends among undocumented patients, and more health news…
STAT News
Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children
Senator Dick Durbin criticizes the Trump administration for allowing flavored e-cigarettes that target children. He…
STAT News
Opinion: The patients demanding unvaccinated blood transfusions
Some patients are requesting blood transfusions from unvaccinated donors due to concerns fueled by misinformation…
STAT News
STAT+: How Stanford patients help expose ‘fault lines’ in health AI adoption
Stanford University is actively involving patients in the development of artificial intelligence tools for healthcare.…
STAT News
‘Are we just going to give up and die like every other generation?’
The Vitalist Bay longevity conference in Berkeley, California, gathered around 100 attendees to explore advancements…
STAT News
Opinion: It’s the end of science as we know it, and I feel fine
“Science itself is inherently resilient — that is, after all, why it’s science,” writes Jonathan Jackson.
STAT News
Trump is seeing doctors for his annual physical. What the public finds out is up to him
President Trump is getting a medical exam on Tuesday, putting his health under renewed public scrutiny after he has…
STAT News
What do early data from Utah’s Doctronic AI pilot show?
Utah has released early data from its pilot program using Doctronic's AI chatbot for prescription renewals. The AI…
STAT
Ebola outbreak continues to worsen, with new collateral risks for girls and women
The Ebola outbreak in the Democratic Republic of Congo is worsening, with 101 confirmed cases and over 900 suspected…
How WeSearch handles this source
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.
Indexing: Allowed
Snippet: Allowed
AI summary: Limited
Retrieval / RAG: Not asserted
Model training: Not asserted
Commercial reuse: Not permitted